Biodesix at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Biodesix brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 544. Its session runs through molecular testing for diagnosis, monitoring and therapeutic development. The company offers diagnostic tests supporting lung cancer decisions, plus testing services for biopharma and research organizations.
| Organization | AMP 2026 Attendance |
|---|---|
Biodesix Louisville, CO | |
Diagnostic tests supporting clinical decisions in lung cancer, plus testing capabilities and services for biopharma and research organizations. | Booth Exhibiting at Booth 544 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 4:00pm–4:50pm Biodesix Comprehensive Molecular Testing Capabilities: Diagnosis, Monitoring, and Therapeutic Development Droplet digital PCR, spatial and sequencing assays used together to monitor cancer treatment response in blood and tissue. |
Instantly find 20 buyers from Biodesix
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction